Alliancebernstein L.P. Galectin Therapeutics Inc Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$2.07 - $5.1 $25,667 - $63,239	-12,400 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$2.24 - $2.87 $3,584 - $4,592	-1,600 Reduced 11.43%	12,400 $28,000
Q3 2020 Nov 12, 2020	SELL	$2.53 - $3.64 $4,807 - $6,916	-1,900 Reduced 11.95%	14,000 $37,000
Q2 2020 Aug 13, 2020	BUY	$1.66 - $3.15 $26,394 - $50,085	15,900 New	15,900 $49,000

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $115M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.